Medical management of chronic ischemic heart disease. Selecting specific drug therapies, modifying risk factors.

about

Medical management of chronic ischemic heart disease. Selecting specific drug therapies, modifying risk factors.

Item

http://www.wikidata.org/entity/Q35682060

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Medical management of chronic ...... apies, modifying risk factors.

@ast

Medical management of chronic ...... apies, modifying risk factors.

@en

type

Item

label

Medical management of chronic ...... apies, modifying risk factors.

@ast

Medical management of chronic ...... apies, modifying risk factors.

@en

prefLabel

Medical management of chronic ...... apies, modifying risk factors.

@ast

Medical management of chronic ...... apies, modifying risk factors.

@en

P1476

Medical management of chronic ...... apies, modifying risk factors.

@en

P2093

Amy C Bales

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

P304

39-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2004.02.1439

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15000059

http://www.w3.org/2001/XMLSchema#string